Oncologi, al via un progetto con l’Iss sul nuovo modello del Cancer driver interception
Risultati per: Collegamenti tra infiammazione e cancro del colon-retto
Questo è quello che abbiamo trovato per te
I numeri del cancro in Italia 2023
Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection of Large Colon Polyps: Use Both for the Best Outcomes
Annals of Internal Medicine, Ahead of Print.
Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection of Large Colon Polyps: Use Both for the Best Outcomes
Annals of Internal Medicine, Ahead of Print.
Una startup di ricerca sul cancro tra i campioni del Made in Italy
Nasce il primo Intergruppo parlamentare per l’innovazione
An Unusual Cause of Severe Wall Thickening and Stenosis of the Sigmoid Colon Accompanied by Polyposis
Effetto dell’aspirina sul trattamento del cancro
Le verdure a foglia verde possono ridurre il rischio di cancro all’intestino
Intelligenza Artificiale per ridurre il trattamento del cancro al seno
Le statine possono ridurre i tassi di mortalità per cancro al seno
Linea guida sul cancro al seno familiare, classificazione, cura e gestione
Cibi industriali legati a cancro, diabete e malattie cardiache
Ogni aumento di 260grammi nei consumi giornalieri +9% di rischio
Cancro ovarico: l’intelligenza artificiale prevede le risposte terapeutiche
Contro cancro cervice immunizzare anche ragazzi anti-Hpv
La conferma da uno studio svolto in Finlandia
Abstract 14540: Allostatic Load/Chronic Toxic Stress and Cardiovascular Outcomes in Breast, Lung and Colon Cancer Patients
Circulation, Volume 148, Issue Suppl_1, Page A14540-A14540, November 6, 2023. Introduction:Cardiovascular disease (CVD) and cancer share a common risk factor: chronic toxic stress/allostatic load (AL). Our previous research found that a 1-point increase in AL is linked to a 25-30% higher risk of major cardiac events (MACE) in prostate cancer patients.Hypothesis:Higher AL is associated with increased MACE risk in patients with breast, lung, and colon cancer.Methods:Patients ≥18 years diagnosed for the first time with the mentioned 3 cancers of interest between 2010-2019 at a large, hybrid academic-community practice were included in this retrospective cohort study. AL was modeled as an ordinal measure (0-11;Table 1). Adjusted Fine-Gray Cox proportional hazard regressions estimated the impact of AL pre- and 60 days post- cancer diagnosis on 2-year MACE.Results:Demographic characteristics are summarized in Table 1. Two-year mace MACE occurred in 12.3%, 23.3%, and 9.7% of breast, lung, and colon cancer patients, respectively. Heart failure was the most common MACE, observed in 7.9%, 14.4%, and 4.8% of breast, lung, and colon cancer patients, respectively. Before cancer diagnosis, a 1-point increase in AL raised MACE risk by 11% (aHR=1.11, 95% CI 1.07-1.16) in breast cancer, 18% (aHR=1.18, 95% CI 1.11-1.25) in lung cancer, and 9% (aHR=1.09, 95% CI 1.01-1.18) in colon cancer. After cancer diagnosis, a 1-point increase in AL increased MACE risk by 10% (aHR=1.10, 95% CI 1.06-1.15) in breast cancer and 19% (aHR=1.19, 95% CI 1.12-1.25) in lung cancer, but was not statistically significant in colon cancer (aHR=1.07, 95% CI 0.99-1.16).Conclusion(s):Higher AL levels prior to breast, lung, and colon cancer diagnoses are associated with increased MACE risk. Thus, effective implementation of patient-centered communication considering stress levels, stressors, and coping mechanisms is necessary during cardiovascular screening for these cancer patients. Further prospective studies are needed.